Jim Simons’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.18M Sell
36,702
-59,900
-62% -$3.89M ﹤0.01% 1855
2025
Q4
$5.96M Sell
96,602
-132,600
-58% -$8.12M 0.01% 1201
2025
Q3
$14.3M Sell
229,202
-176,602
-44% -$12.3M 0.02% 897
2025
Q2
$32.4M Buy
405,804
+37,500
+10% +$3.14M 0.04% 505
2025
Q1
$31.7M Buy
368,304
+60,900
+20% +$5M 0.05% 475
2024
Q4
$24M Sell
307,404
-20,198
-6% -$1.57M 0.04% 586
2024
Q3
$23.6M Sell
327,602
-46,200
-12% -$3.27M 0.04% 593
2024
Q2
$25.7M Buy
373,802
+15,100
+4% +$1.02M 0.04% 496
2024
Q1
$26M Buy
358,702
+4,700
+1% +$314K 0.04% 522
2023
Q4
$21.7M Sell
354,002
-46,200
-12% -$2.74M 0.03% 588
2023
Q3
$22.9M Buy
400,202
+43,100
+12% +$2.6M 0.04% 519
2023
Q2
$21.2M Buy
357,102
+17,300
+5% +$1.04M 0.03% 649
2023
Q1
$21.3M Buy
339,802
+7,500
+2% +$468K 0.03% 677
2022
Q4
$20.8M Sell
332,302
-18,400
-5% -$1.06M 0.03% 693
2022
Q3
$17.5M Sell
350,702
-22,700
-6% -$1.26M 0.02% 742
2022
Q2
$22M Buy
373,402
+66,300
+22% +$3.66M 0.03% 680
2022
Q1
$16.3M Sell
307,102
-58,800
-16% -$3.4M 0.02% 878
2021
Q4
$22.2M Buy
365,902
+112,800
+45% +$6.7M 0.03% 656
2021
Q3
$14.2M Buy
253,102
+32,100
+15% +$1.76M 0.02% 840
2021
Q2
$11.5M Buy
221,002
+28,200
+15% +$1.35M 0.01% 1082
2021
Q1
$8.5M Sell
192,802
-151,300
-44% -$6.36M 0.01% 1295
2020
Q4
$12M Sell
344,102
-48,800
-12% -$1.73M 0.01% 1046
2020
Q3
$14.3M Sell
392,902
-19,100
-5% -$710K 0.01% 920
2020
Q2
$15.5M Buy
412,002
+347,200
+536% +$13.9M 0.01% 964
2020
Q1
$2.38M Buy
+64,802
New +$2.52M ﹤0.01% 1967
2019
Q3
Sell
-29,300
Closed -$928K 3632
2019
Q2
$928K Buy
+29,300
New +$871K ﹤0.01% 2710
2019
Q1
Sell
-17,600
Closed -$543K 3631
2018
Q4
$543K Sell
17,600
-52,600
-75% -$1.92M ﹤0.01% 2834
2018
Q3
$2.66M Buy
+70,200
New +$2.66M ﹤0.01% 2145
2018
Q2
Sell
-37,300
Closed -$1.26M 3458
2018
Q1
$1.26M Sell
37,300
-302,700
-89% -$11.6M ﹤0.01% 2560
2017
Q4
$15.1M Buy
340,000
+189,100
+125% +$8.61M 0.02% 1136
2017
Q3
$7.56M Sell
150,900
-365,600
-71% -$18.7M 0.01% 1502
2017
Q2
$27.3M Buy
516,500
+30,500
+6% +$1.63M 0.03% 670
2017
Q1
$27M Buy
486,000
+94,500
+24% +$5.21M 0.04% 627
2016
Q4
$20.4M Sell
391,500
-288,600
-42% -$13.9M 0.03% 766
2016
Q3
$32.8M Buy
680,100
+199,300
+41% +$10.1M 0.06% 440
2016
Q2
$26.6M Sell
480,800
-64,600
-12% -$3.56M 0.05% 520
2016
Q1
$29.1M Buy
545,400
+149,300
+38% +$7.35M 0.06% 454
2015
Q4
$20.4M Buy
396,100
+239,700
+153% +$11.9M 0.04% 534
2015
Q3
$7.06M Buy
156,400
+139,100
+804% +$6.57M 0.02% 1147
2015
Q2
$800K Buy
+17,300
New +$757K ﹤0.01% 2556
2014
Q1
Sell
-520,500
Closed -$18.6M 2967
2013
Q4
$18.6M Sell
520,500
-141,600
-21% -$4.7M 0.04% 494
2013
Q3
$19.9M Buy
662,100
+359,600
+119% +$11.8M 0.05% 475
2013
Q2
$8.81M Buy
+302,500
New +$8.53M 0.02% 808

Other funds holding PBH

Jim Simons's PBH Position: Q1 2026 in Review

Jim Simons reduced its Prestige Consumer Healthcare (PBH) stake by 62% in Q1 2026, selling an estimated $3.89M and leaving 36,702 shares worth $2.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1855.

Jim Simons first reported a position in PBH in Q2 2013 and has held it in 43 quarters since. The position peaked at $32.8M in Q3 2016. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Jim Simons held 36,702 shares of Prestige Consumer Healthcare worth $2.18M as of Q1 2026.
  • Jim Simons sold 59,900 Prestige Consumer Healthcare shares in Q1 2026, an estimated $3.89M.
  • Prestige Consumer Healthcare made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #1855 holding.
  • Jim Simons first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 43 quarters since.
  • Jim Simons's Prestige Consumer Healthcare position peaked at $32.8M in Q3 2016.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.